论文部分内容阅读
目的分析喜炎平联合思密达治疗小儿腹泻的临床疗效。方法选取在我院治疗的76例腹泻患儿,随机分为2组,其中治疗组40例、对照组36例。对照组口服思密达,治疗组在此基础上静脉滴注喜炎平。1周后观察并比较2组的临床疗效、症状改善时间及住院时间。结果治疗组的显效率(72.50%)明显高于对照组(44.44%),总有效率(92.50%)也明显高于对照组(66.67%),2组比较差异有统计意义(P<0.05);治疗组的退热时间、脱水纠正时间、便次正常时间、大便性状正常时间、住院时间均显著短于对照组(P<0.05)。结论喜炎平联合思密达治疗小儿腹泻具有良好的临床疗效,可明显改善患儿的临床症状,安全可靠、无不良反应,值得临床推广。
Objective To analyze the clinical effect of Xiyanping combined with Smecta in treating infantile diarrhea. Methods Totally 76 children with diarrhea who were treated in our hospital were randomly divided into 2 groups, including 40 in the treatment group and 36 in the control group. The control group oral smecta, the treatment group on the basis of intravenous infusion of Xiyanping. One week later, the clinical efficacy, symptom improvement and hospital stay were observed and compared. Results The effective rate (72.50%) in the treatment group was significantly higher than that in the control group (44.44%), and the total effective rate (92.50%) was also significantly higher than that in the control group (66.67% ; Treatment group antipyretic time, dehydration correction time, normal times, normal stool stool time, hospitalization were significantly shorter than the control group (P <0.05). Conclusion Xiyanping combined with Smectite treatment of children with diarrhea has a good clinical efficacy, can significantly improve the clinical symptoms of children, safe and reliable, no adverse reactions, is worth clinical promotion.